The future of health:
Our expertise in respiratory health

Pollution, smoking habits, allergies: chronic respiratory diseases, such as asthma or chronic obstructive pulmonary disease (COPD), are on the rise.

It is estimated that in 2050, there will be 600 millions COPD patients in the world (1). Uncontrolled asthma is projected to cost 300 $billions in the next 20 years in the US (2).

For public policy makers and pharma companies alike, it’s a huge challenge to understand how to prevent, diagnose and manage better respiratory conditions.

We’ve worked on several projects shaping the future of respiratory health:

Respiratory - Think Next
Respiratory - Think Next
Respiratory - Think Next

Explore our case studies

If you’re curious about our experience in Respiratory, explore our case studies below & reach out to us for more information!

Respiratory conditions we’ve worked on: Asthma, COPD, Chronic Cough, NCFBE

Digital health innovation: profile of early adopters

Understanding adopter and non-adopter profiles with segmentation analysis

Disease area strategy: patient expectations for 2030

Shaping the disease area strategy and early drug development to meet patient expectations in 2030

Digital Therapeutics Landscape and patient adoption

Building the case for change for Digital Therapeutics in a large pharmaceutical company

Innovation with connected drug device

Investigating the opportunity for a connected drug device with patients & caregivers – a winning case for change?

Unique insights from our patient trendscoping study

Additionally, with more than 1000 respondents with a respiratory condition, our Patient Trendscoping study is also a source of unique insights on patient expectations and behaviours.

With sizable patient groups in conditions such as asthma, COPD or chronic cough, we can delve into the trends that resonate the most with each group.